Cetera Advisor Networks’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $7.15M | Sell |
73,905
-2,281
| -3% | -$234K | 0.04% | 485 |
|
|
2023
Q4 | $7.69M | Buy |
76,186
+790
| +1% | +$76.3K | 0.04% | 419 |
|
|
2023
Q3 | $7.68M | Buy |
75,396
+6,591
| +10% | +$669K | 0.05% | 378 |
|
|
2023
Q2 | $6.94M | Buy |
68,805
+6,451
| +10% | +$645K | 0.05% | 383 |
|
|
2023
Q1 | $5.74M | Buy |
62,354
+365
| +0.6% | +$31.9K | 0.04% | 426 |
|
|
2022
Q4 | $5.62M | Buy |
61,989
+25,192
| +68% | +$2.12M | 0.05% | 420 |
|
|
2022
Q3 | $2.8M | Buy |
36,797
+3,173
| +9% | +$263K | 0.03% | 480 |
|
|
2022
Q2 | $2.84M | Buy |
33,624
+4,039
| +14% | +$354K | 0.04% | 476 |
|
|
2022
Q1 | $2.6M | Buy |
29,585
+1,196
| +4% | +$104K | 0.03% | 530 |
|
|
2021
Q4 | $2.48M | Buy |
28,389
+303
| +1% | +$25.2K | 0.03% | 529 |
|
|
2021
Q3 | $2.3M | Sell |
28,086
-405
| -1% | -$36.4K | 0.03% | 503 |
|
|
2021
Q2 | $2.6M | Buy |
28,491
+20,790
| +270% | +$1.85M | 0.04% | 447 |
|
|
2021
Q1 | $658K | Sell |
7,701
-3,370
| -30% | -$302K | 0.01% | 748 |
|
|
2020
Q4 | $1.04M | Sell |
11,071
-489
| -4% | -$42.7K | 0.02% | 526 |
|
|
2020
Q3 | $1M | Sell |
11,560
-1,229
| -10% | -$106K | 0.03% | 476 |
|
|
2020
Q2 | $1.12M | Sell |
12,789
-134
| -1% | -$11.6K | 0.03% | 440 |
|
|
2020
Q1 | $1.07M | Buy |
12,923
+61
| +0.5% | +$5.44K | 0.04% | 394 |
|
|
2019
Q4 | $1.22M | Buy |
12,862
+305
| +2% | +$27.4K | 0.03% | 437 |
|
|
2019
Q3 | $1.09M | Sell |
12,557
-806
| -6% | -$72.4K | 0.03% | 442 |
|
|
2019
Q2 | $1.22M | Sell |
13,363
-1,310
| -9% | -$111K | 0.04% | 395 |
|
|
2019
Q1 | $1.26M | Sell |
14,673
-1,063
| -7% | -$85.3K | 0.04% | 355 |
|
|
2018
Q4 | $1.21M | Sell |
15,736
-1,383
| -8% | -$108K | 0.05% | 327 |
|
|
2018
Q3 | $1.32M | Buy |
17,119
+2,744
| +19% | +$203K | 0.05% | 323 |
|
|
2018
Q2 | $976K | Buy |
14,375
+230
| +2% | +$15.9K | 0.05% | 300 |
|
|
2018
Q1 | $1.02M | Buy |
14,145
+3,380
| +31% | +$257K | 0.05% | 320 |
|
|
2017
Q4 | $808K | Sell |
10,765
-498
| -4% | -$37.6K | 0.03% | 429 |
|
|
2017
Q3 | $872K | Buy |
11,263
+346
| +3% | +$26.1K | 0.04% | 371 |
|
|
2017
Q2 | $819K | Sell |
10,917
-98
| -0.9% | -$6.95K | 0.04% | 372 |
|
|
2017
Q1 | $732K | Buy |
11,015
+452
| +4% | +$30.1K | 0.03% | 396 |
|
|
2016
Q4 | $691K | Sell |
10,563
-5,608
| -35% | -$364K | 0.04% | 384 |
|
|
2016
Q3 | $1.14M | Buy |
16,171
+5,225
| +48% | +$381K | 0.04% | 344 |
|
|
2016
Q2 | $808K | Sell |
10,946
-1,109
| -9% | -$76.6K | 0.05% | 337 |
|
|
2016
Q1 | $782K | Buy |
12,055
+1,476
| +14% | +$100K | 0.05% | 337 |
|
|
2015
Q4 | $818K | Sell |
10,579
-1,088
| -9% | -$86.4K | 0.05% | 317 |
|
|
2015
Q3 | $958K | Sell |
11,667
-531
| -4% | -$47.3K | 0.07% | 272 |
|
|
2015
Q2 | $1.08M | Hold |
12,198
| – | – | 0.07% | 271 |
|
|
2015
Q1 | $1.08M | Sell |
12,198
-1,098
| -8% | -$97.4K | 0.07% | 272 |
|
|
2014
Q4 | $1.1M | Sell |
13,296
-834
| -6% | -$69.1K | 0.08% | 254 |
|
|
2014
Q3 | $1.19M | Sell |
14,130
-4,367
| -24% | -$353K | 0.08% | 240 |
|
|
2014
Q2 | $1.5M | Buy |
18,497
+872
| +5% | +$68.6K | 0.1% | 224 |
|
|
2014
Q1 | $1.35M | Buy |
17,625
+1,532
| +10% | +$112K | 0.1% | 224 |
|
|
2013
Q4 | $1.15M | Buy |
16,093
+471
| +3% | +$32.7K | 0.09% | 241 |
|
|
2013
Q3 | $1.08M | Sell |
15,622
-1,060
| -6% | -$70.1K | 0.09% | 213 |
|
|
2013
Q2 | $1.05M | Buy |
+16,682
| New | +$1.09M | 0.1% | 192 |
|
Other funds holding NVS
Cetera Advisor Networks's NVS Position: Q1 2024 in Review
Cetera Advisor Networks reduced its Novartis (NVS) stake by 3% in Q1 2024, selling an estimated $234K and leaving 73,905 shares worth $7.15M. The position accounts for 0.04% of the portfolio, ranked #485.
Cetera Advisor Networks first reported a position in NVS in Q2 2013 and has held it in 44 quarters since. The position peaked at $7.69M in Q4 2023. 1,254 funds tracked by Wall St. Rank hold NVS as of Q1 2024.
- Cetera Advisor Networks held 73,905 shares of Novartis worth $7.15M as of Q1 2024.
- Cetera Advisor Networks sold 2,281 Novartis shares in Q1 2024, an estimated $234K.
- Novartis made up 0.04% of Cetera Advisor Networks's portfolio in Q1 2024, its #485 holding.
- Cetera Advisor Networks first reported a position in Novartis in Q2 2013 and has held it in 44 quarters since.
- Cetera Advisor Networks's Novartis position peaked at $7.69M in Q4 2023.
- 1,254 funds tracked by Wall St. Rank held Novartis as of Q1 2024.
Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.